Related Experiment Video
Updated: Aug 8, 2026
09:32
Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions
Published on: November 11, 2015
Efficient gene transfer to airway epithelium using recombinant Sendai virus
Y Yonemitsu1, C Kitson, S Ferrari
1Department of Gene Therapy, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK.
Nature Biotechnology
|September 6, 2000
Summary
Recombinant Sendai virus (SeV) offers efficient gene transfer to the airway epithelium, overcoming key challenges in cystic fibrosis (CF) gene therapy. This novel vector shows superior performance compared to existing methods in preclinical models.
Area of Science:
- Biotechnology
- Gene Therapy
- Respiratory Medicine
Background:
- Gene therapy for cystic fibrosis (CF) faces challenges in efficient gene transfer to airway epithelium.
- Vector receptor availability, short contact times, and mucus barrier impede current methods.
Purpose of the Study:
- To evaluate recombinant Sendai virus (SeV) as a novel gene transfer vector for airway epithelium.
- To compare SeV's efficiency against existing gene transfer agents.
Main Methods:
- Development of recombinant Sendai virus (SeV) for gene transfer.
- In vivo studies in mice and ferrets, and in vitro studies with human nasal epithelial cells.
- Comparison of SeV transfection efficiency with cationic liposomes and adenovirus.
Main Results:
- SeV demonstrated highly efficient transfection throughout the respiratory tract in vivo and in vitro.
- Gene transfer efficiency with SeV was several log orders greater than with liposomes or adenovirus.
- SeV maintained high efficiency even with brief contact times and was not significantly hindered by airway mucus.
Conclusions:
- Recombinant Sendai virus (SeV) is a promising new vector for efficient airway gene transfer.
- SeV overcomes major limitations of current gene therapy vectors for cystic fibrosis.
- Further investigation of SeV for therapeutic applications in airway diseases is warranted.
